10.1186/s13058-016-0686-4 - Mcl-1 confers protection of Her2-posi...

This document has been corrected

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

10.1186/s13058-016-0686-4

Published Online: 2016-02-26

Journal: Breast Cancer Research•Publisher: Springer Science and Business Media LLC

Authors: Andreas Schneeweiss•Claudia Luckner-Minden•Dirk Jäger•Fengjuan Fan•Frederik Marme•Henning Schulze-Bergkamen•Inka Zörnig•Joseph T. Opferman•Klaus Podar•Martin Sattler•Melissa Arn•Michael H. Cardone•Muhammad Hasan Bashari•Sonia Vallet

This document has been corrected

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

10.1186/s13058-016-0686-4

Published Online: 2016-02-26

Journal: Breast Cancer Research

NOW

2024-04-02•Correction

Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

10.1186/s13058-024-01811-y

* information provided by CrossRef

2024-04-02•Correction

10.1186/s13058-024-01811-y

* information provided by CrossRef

2016-02-26•Published

2024-04-02•Correction

Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

10.1186/s13058-024-01811-y

* information provided by CrossRef

This document has been corrected

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

10.1186/s13058-016-0686-4

Published Online: 2016-02-26

Journal: Breast Cancer Research•Publisher: Springer Science and Business Media LLC